abstract |
The present invention relates to novel trifluoromethyl substituted fused pyrimidines, to a process for their preparation, to their use, alone or in combination, for the treatment and/or prophylaxis of diseases, and to the use thereof for the treatment and/or prevention of diseases The use of pharmaceuticals, particularly for the treatment and/or prevention of cardiovascular disorders. |